1. Home
  2. QURE vs MBWM Comparison

QURE vs MBWM Comparison

Compare QURE & MBWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QURE
  • MBWM
  • Stock Information
  • Founded
  • QURE 1998
  • MBWM 1997
  • Country
  • QURE Netherlands
  • MBWM United States
  • Employees
  • QURE N/A
  • MBWM N/A
  • Industry
  • QURE Biotechnology: Pharmaceutical Preparations
  • MBWM Major Banks
  • Sector
  • QURE Health Care
  • MBWM Finance
  • Exchange
  • QURE Nasdaq
  • MBWM Nasdaq
  • Market Cap
  • QURE 866.3M
  • MBWM 791.0M
  • IPO Year
  • QURE 2007
  • MBWM 1997
  • Fundamental
  • Price
  • QURE $17.10
  • MBWM $48.31
  • Analyst Decision
  • QURE Strong Buy
  • MBWM Buy
  • Analyst Count
  • QURE 11
  • MBWM 4
  • Target Price
  • QURE $39.91
  • MBWM $53.63
  • AVG Volume (30 Days)
  • QURE 966.4K
  • MBWM 48.2K
  • Earning Date
  • QURE 11-04-2025
  • MBWM 10-14-2025
  • Dividend Yield
  • QURE N/A
  • MBWM 3.08%
  • EPS Growth
  • QURE N/A
  • MBWM N/A
  • EPS
  • QURE N/A
  • MBWM 5.03
  • Revenue
  • QURE $14,337,000.00
  • MBWM $228,384,000.00
  • Revenue This Year
  • QURE N/A
  • MBWM $10.34
  • Revenue Next Year
  • QURE $301.10
  • MBWM $11.93
  • P/E Ratio
  • QURE N/A
  • MBWM $9.55
  • Revenue Growth
  • QURE N/A
  • MBWM 3.70
  • 52 Week Low
  • QURE $4.45
  • MBWM $37.76
  • 52 Week High
  • QURE $19.18
  • MBWM $52.98
  • Technical
  • Relative Strength Index (RSI)
  • QURE 60.57
  • MBWM 52.52
  • Support Level
  • QURE $16.69
  • MBWM $47.61
  • Resistance Level
  • QURE $17.76
  • MBWM $48.38
  • Average True Range (ATR)
  • QURE 0.77
  • MBWM 1.06
  • MACD
  • QURE 0.01
  • MBWM -0.14
  • Stochastic Oscillator
  • QURE 62.76
  • MBWM 32.87

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About MBWM Mercantile Bank Corporation

Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.

Share on Social Networks: